• English
  • Singapore(USD $)
  • $ USD
  • $ CAD
  • S$ SGD

No relevant currency found

CLOSE

/ /

Tongxinluo - Basic Drug for Cardiovascular Diseases.

Jun 19,2023 | YILING

Overview of cardiovascular diseases

The population of suffer from cardiovascular diseases with high mortality

 

Cardiovascular disease continuum: Cardiovascular events source from risk factors, including diabetes, dyslipidemia, hypertension. If these factors are not intervened in early stage, they will inevitably develop into atherosclerosis, coronary artery disease, angina pectoris, myocardial infarction, etc., eventually leading to heart failure and death.

 

Conventional treatment of cardiovascular diseases

Disease progress cannot be completely controlled with conventional treatment

In a study to observe the relationship between plaque area and cardiovascular and cerebrovascular events, 1,686 patients with stroke, TIA or symptomatic carotid stenosis were included, with an average follow-up of 2.5 ± 1.3 years. The results indicate that, even if the risk factors were actively intervened, nearly 60% of patients still had progression of atherosclerotic plaque.

       Advantages of Tongxinluo

Tongxinluo Capsule Won the First prize of National Science and Technology Award

Tongxinluo Capsule won four major awards and was recognized by national authority

1.Yiling Pharmaceutical won the first prize of National Scientific and Technological Progress Award in 2019 for the study of vascular lesions; Tongxinluo Capsule, Shensong Yangxin Capsule, Qili Qiangxin Capsule are the only traditional Chinese medicines that were granted the national honor

2."Research on Tongxinluo Capsule in the treatment of coronary heart disease" won the second prize of National Scientific and Technological Progress Award in 2000;

3."Research on the theory of collateral diseases and its application" won the second prize of National Scientific and Technological Progress Award in 2006;

4."Ultramicrogrinding (micron) technology of worm medicines and its application" won the second prize of National Technical Invention Award in 2007;

Tongxinluo innovatively construct the collateral theory
"search, remove and dredge”

Tongxinluo-Formulation Advantages

Tongxinluo Capsule - basic drug for cardiovascular disease

Researches have shown that Tongxinluo Capsule has triple protective effects on cardiovascular disease, including blood protection, vascular protection, and cardio-cerebral ischemia protection

 

 

Comment

Name
Email
Comment